NEW YORK (GenomeWeb News) – Response Genetics announced today contracts with Blue Cross and Blue Shield of Minnesota and Blue Cross and Blue Shield of Nebraska.

The Los Angeles-based molecular diagnostic company is now in-network with eight Blue Cross Blue Shield plans. Today's announcement follows agreements inked between Response Genetics and four payors last month.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.